Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Nanomedicine. 2015 Jan 31;11(5):1277–1283. doi: 10.1016/j.nano.2014.12.016

Figure 3.

Figure 3

Clonogenic survival fraction of PC3 cells treated with goserelin-conjugated gold nanorods (gAuNRs) and pegylated gold nanorods (pAuNRs) for 24h prior to irradiation with 6MV beam. Inset table shows radiosensitization enhancement fraction (REF) obtained at 10% survival fraction. Conjugated nanoparticles, gAuNRs, were found to radiosensitize cancer cells significantly more than pegylated gold nanoparticles (p<0.0001).